BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30705095)

  • 1. CD371 cell surface expression: a unique feature of
    Schinnerl D; Mejstrikova E; Schumich A; Zaliova M; Fortschegger K; Nebral K; Attarbaschi A; Fiser K; Kauer MO; Popitsch N; Haslinger S; Inthal A; Buldini B; Basso G; Bourquin JP; Gaipa G; Brüggemann M; Feuerstein T; Maurer-Granofszky M; Panzer-Grümayer R; Trka J; Mann G; Haas OA; Hrusak O; Dworzak MN; Strehl S
    Haematologica; 2019 Aug; 104(8):e352-e355. PubMed ID: 30705095
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zaliova M; Potuckova E; Hovorkova L; Musilova A; Winkowska L; Fiser K; Stuchly J; Mejstrikova E; Starkova J; Zuna J; Stary J; Trka J
    Haematologica; 2019 Jul; 104(7):1407-1416. PubMed ID: 30630977
    [No Abstract]   [Full Text] [Related]  

  • 4. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
    Zhang J; McCastlain K; Yoshihara H; Xu B; Chang Y; Churchman ML; Wu G; Li Y; Wei L; Iacobucci I; Liu Y; Qu C; Wen J; Edmonson M; Payne-Turner D; Kaufmann KB; Takayanagi SI; Wienholds E; Waanders E; Ntziachristos P; Bakogianni S; Wang J; Aifantis I; Roberts KG; Ma J; Song G; Easton J; Mulder HL; Chen X; Newman S; Ma X; Rusch M; Gupta P; Boggs K; Vadodaria B; Dalton J; Liu Y; Valentine ML; Ding L; Lu C; Fulton RS; Fulton L; Tabib Y; Ochoa K; Devidas M; Pei D; Cheng C; Yang J; Evans WE; Relling MV; Pui CH; Jeha S; Harvey RC; Chen IL; Willman CL; Marcucci G; Bloomfield CD; Kohlschmidt J; Mrózek K; Paietta E; Tallman MS; Stock W; Foster MC; Racevskis J; Rowe JM; Luger S; Kornblau SM; Shurtleff SA; Raimondi SC; Mardis ER; Wilson RK; Dick JE; Hunger SP; Loh ML; Downing JR; Mullighan CG;
    Nat Genet; 2016 Dec; 48(12):1481-1489. PubMed ID: 27776115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
    Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia.
    Sun J; Yu W; Zhang X
    Ann Hematol; 2020 Jan; 99(1):185-188. PubMed ID: 31781846
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement.
    Imamura T; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Ishii E; Imashuku S
    Br J Haematol; 2002 Oct; 119(1):119-21. PubMed ID: 12358913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NG2 antigen in MLL-rearranged acute leukemias: how complex does it get?
    Menendez P; Bueno C
    Leuk Res; 2011 Aug; 35(8):989-90. PubMed ID: 21492935
    [No Abstract]   [Full Text] [Related]  

  • 9. N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).
    Siegele BJ; Stemmer-Rachamimov AO; Lilljebjorn H; Fioretos T; Winters AC; Dal Cin P; Treece A; Gaskell A; Nardi V
    Genes Chromosomes Cancer; 2022 Aug; 61(8):449-458. PubMed ID: 35218117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor gamma and delta junctional gene rearrangements as diagnostic and prognostic biomarker for T-cell acute lymphoblastic leukemia.
    Kode J; Dudhal N; Banavali S; Chiplunkar S
    Leuk Lymphoma; 2006 Apr; 47(4):769-70. PubMed ID: 16886283
    [No Abstract]   [Full Text] [Related]  

  • 12. Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia.
    Stanulla M; Schrauder A
    Haematologica; 2009 Jun; 94(6):748-52. PubMed ID: 19483150
    [No Abstract]   [Full Text] [Related]  

  • 13. Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia.
    Riedt T; Ebinger M; Salih HR; Tomiuk J; Handgretinger R; Kanz L; Grünebach F; Lengerke C
    Blood; 2009 Apr; 113(17):4049-51. PubMed ID: 19218548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia.
    Campolungo D; Salomé M; Biferali B; Tascini AS; Gabellini D
    Sci Adv; 2023 Sep; 9(37):eadi3771. PubMed ID: 37713484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ; Schneider P; Pieters R; Stam RW
    Eur J Cancer; 2015 Sep; 51(14):2008-21. PubMed ID: 26188848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular biology and childhood leukemia: E2A-PBX1 and central nervous system relapse].
    Núñez-Enríquez JC; Mejía-Aranguré JM
    Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 3():S236-9. PubMed ID: 26509298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
    Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.
    Stam RW; Schneider P; de Lorenzo P; Valsecchi MG; den Boer ML; Pieters R
    Blood; 2007 Oct; 110(7):2774-5. PubMed ID: 17881645
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.
    Oliveira T; Zhang M; Joo EJ; Abdel-Azim H; Chen CW; Yang L; Chou CH; Qin X; Chen J; Alagesan K; Almeida A; Jacob F; Packer NH; von Itzstein M; Heisterkamp N; Kolarich D
    Theranostics; 2021; 11(19):9519-9537. PubMed ID: 34646384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rearranged patterns of IgH and TcR gamma genes in patients with acute lymphoblastic leukemia.
    Li S; Wang B; Li C
    J Tongji Med Univ; 1997; 17(4):206-8. PubMed ID: 9812780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.